-
Nursing home flu outbreaks—statistical approach reveals keys to preventing hospitalizations
In nursing homes, influenza spreads quickly. Even in facilities with separate wings, staff move throughout the home, caring for medically... Read more -
Common antidepressant may ease long COVID fatigue
A randomized clinical trial found that the antidepressant fluvoxamine significantly reduces long COVID-related fatigue, one of the condition's most persistent... Read more -
New discovery could slow Parkinson's disease and reduce life-threatening lung injury
Scientists at Florida International University have developed a promising new compound that could slow the progression of Parkinson's disease and... Read more -
Mirror fragments intercept Alzheimer's-causing protein
Understanding how proteins interact with their own mirror images enabled a Kobe University research team to design a small mirror... Read more -
Common antidepressant eases fatigue associated with long COVID, study finds
A global research team co‑led by McMaster University has identified one of the first medications shown to meaningfully reduce fatigue... Read more -
Sotatercept shows promise for a type of pulmonary hypertension linked to heart failure with preserved EF
Patients who have heart failure with preserved ejection fraction (HFpEF) and high blood pressure in the lungs (pulmonary hypertension) experienced... Read more -
Investigational drug delivers mixed results for uncontrolled blood pressure
The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, a protein that turns... Read more -
Mavacamten improves obstruction in adolescents with hypertrophic cardiomyopathy
Adolescent patients with obstructive hypertrophic cardiomyopathy (HCM) who received the drug mavacamten saw a significant improvement in left ventricular outflow... Read more -
Organ-on-a-chip technology replicates decades of human aging in just four days
Over one billion people worldwide are over 60, and the population is projected to more than double by 2050. But... Read more -
Brain wiring model could shorten path to new medicines
A new, more life-like physical model of microscopic nerve fibers called axons could speed up the discovery of medicines for... Read more -
Switching to integrase inhibitors from protease inhibitors is associated with new diabetes risk in people with HIV
Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according... Read more -
Triglyceride-lowering drug does not affect plaque in arteries at one year in patients with elevated triglycerides: Study
Despite experiencing significant reductions in triglycerides, patients with triglycerides over 150 mg/dL and a high risk of atherosclerosis did not... Read more -
uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and lymphoma.... Read more -
Switching from dulaglutide to tirzepatide boosts patient-reported well-being for people with type 2 diabetes: Analysis
An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from... Read more -
New compound MF-8 may treat anxiety and memory loss with fewer side effects
Scientists at City University of Hong Kong (CityUHK) have made progress in recent months with the discovery of a novel... Read more
